Evolution Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Evolution Advisers’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$78K	Hold	160	–	–	0.03%	72
2025 Q4	$92K	Hold	160	–	–	0.04%	64
2025 Q3	$84K	Hold	160	–	–	0.04%	70
2025 Q2	$64K	Hold	160	–	–	0.03%	79
2025 Q1	$79K	Hold	160	–	–	0.04%	69
2024 Q4	$83K	Hold	160	–	–	0.05%	71
2024 Q3	$98K	Hold	160	–	–	0.05%	62
2024 Q2	$88K	Hold	160	–	–	0.05%	65
2024 Q1	$93K	Hold	160	–	–	0.05%	64
2023 Q4	$87K	Hold	160	–	–	0.06%	61
2023 Q3	$80K	Hold	160	–	–	0.06%	53
2023 Q2	$83K	Hold	160	–	–	0.06%	54
2023 Q1	$92K	Hold	160	–	–	0.07%	48
2022 Q4	$88K	Hold	160	–	–	0.07%	44
2022 Q3	$81K	Hold	160	–	–	0.07%	44
2022 Q2	$87K	Hold	160	–	–	0.07%	48
2022 Q1	$94K	Hold	160	–	–	0.07%	47
2021 Q4	$106K	Buy	+160	New	+$99.9K	0.08%	40

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Evolution Advisers's TMO Position: Q1 2026 in Review

Evolution Advisers held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 160 shares worth $78K. The position accounts for 0.03% of the portfolio, ranked #72.

Evolution Advisers first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $106K in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Evolution Advisers held 160 shares of Thermo Fisher Scientific worth $78K as of Q1 2026.
Evolution Advisers left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.03% of Evolution Advisers's portfolio in Q1 2026, its #72 holding.
Evolution Advisers first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
Evolution Advisers's Thermo Fisher Scientific position peaked at $106K in Q4 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Evolution Advisers's 13F filing for Q1 2026, filed 1 May 2026.